Organovo Holdings Inc (AMEX:ONVO) had its target price reduced by research analysts at Evercore ISI from $4.00 to $3.75 in a report released on Monday, reports. The brokerage currently has an “outperform” rating on the medical research company’s stock. Evercore ISI’s target price points to a potential upside of 39.41% from the stock’s current price.

Organovo Holdings (AMEX ONVO) traded down 1.12% during mid-day trading on Monday, hitting $2.66. 646,033 shares of the company were exchanged. The stock’s 50 day moving average is $2.82 and its 200-day moving average is $3.16. Organovo Holdings has a 12-month low of $2.48 and a 12-month high of $4.99.

COPYRIGHT VIOLATION WARNING: This piece of content was first reported by American Banking News and is the sole property of of American Banking News. If you are reading this piece of content on another publication, it was illegally stolen and reposted in violation of U.S. and international trademark & copyright legislation. The correct version of this piece of content can be viewed at

About Organovo Holdings

Stock Target Prices

Receive News & Ratings for Organovo Holdings Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Organovo Holdings Inc and related companies with's FREE daily email newsletter.